Lifeline Overview
Lifeline Ventures is a Helsinki-based early-stage venture capital firm founded in 2009 by serial entrepreneurs Timo Ahopelto and Petteri Koponen. The firm partners with founders from the very beginning of their journey, providing support throughout their growth. Lifeline Ventures has invested in over 100 companies, including notable exits like Supercell, Wolt, and Oura Health. Their investment ticket size ranges from €150,000 to €2 million, participating in angel, seed, and Series A rounds. The firm is sector-agnostic, with investments spanning software, health care, apps, climate technology, consumer, finance, games, and hardware sectors.
Is Lifeline the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Lifeline, along with a list of other relevant VCs, is available on Hopohopo.io.
Lifeline
Investment focus
Invest in
- Nordics 1 / 9
Investment role
Lead and follow
Stages
Pre-seed, Seed
First ticket size
€150,000 - €2,000,000
Contact information
Founding Partner
Timo Ahopelto
General Partner
Jyri Engestroem
Partner and CFO
Elina Holkko
Founding Partner
Petteri Koponen
Partner
Juha Lindfors
How to approach funds like Lifeline
When reaching out to Lifeline Ventures, highlight your ambition to build globally significant companies from the ground up and demonstrate a founder-driven vision. They value teams with deep domain expertise and a bold, long-term outlook, especially those tackling complex or underserved markets. Be candid about your challenges and how you plan to overcome them, as they appreciate transparency and resilience in founders. Show how your solution can scale internationally and why your team is uniquely positioned to execute.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
